Rajiv Tandon

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
    Rajiv Tandon
    University of Florida, Tallahassee, USA
    Schizophr Res 100:20-38. 2008
  2. ncbi The nosology of schizophrenia: toward DSM-5 and ICD-11
    Rajiv Tandon
    Department of Psychiatry, University of Florida, PO Box 103424, Gainesville, FL 32610 3424, USA
    Psychiatr Clin North Am 35:557-69. 2012
  3. ncbi Antipsychotics in the treatment of schizophrenia: an overview
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32610 3424, USA
    J Clin Psychiatry 72:4-8. 2011
  4. ncbi Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future
    Rajiv Tandon
    University of Florida, Department of Psychiatry, FL, USA
    Schizophr Res 122:1-23. 2010
  5. ncbi Defining and measuring clinical effectiveness in the treatment of schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Psychiatr Serv 56:273-82. 2005
  6. ncbi Schizophrenia, "just the facts" 4. Clinical features and conceptualization
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, P O Box 100256, Gainesville, FL 32610, USA
    Schizophr Res 110:1-23. 2009
  7. ncbi Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Mississippi Medical Center, Jackson, Miss, USA
    J Clin Psychiatry 63:12-20. 2002
  8. ncbi Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
    Rajiv Tandon
    Department of Psychiatry (Adjunct, University of Florida, Gainesville, FL, USA
    Psychiatry Res 136:211-21. 2005
  9. ncbi Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse
    Matcheri S Keshavan
    Department of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School, Boston, MA 02215, USA
    Schizophr Res 127:3-13. 2011
  10. ncbi Should overeating and obesity be classified as an addictive disorder in DSM-5?
    Claudia Moreno
    University of Florida College of Medicine, Department of Psychiatry, Gainesville, FL 32611, USA
    Curr Pharm Des 17:1128-31. 2011

Detail Information

Publications10

  1. ncbi World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
    Rajiv Tandon
    University of Florida, Tallahassee, USA
    Schizophr Res 100:20-38. 2008
    ....
  2. ncbi The nosology of schizophrenia: toward DSM-5 and ICD-11
    Rajiv Tandon
    Department of Psychiatry, University of Florida, PO Box 103424, Gainesville, FL 32610 3424, USA
    Psychiatr Clin North Am 35:557-69. 2012
    ....
  3. ncbi Antipsychotics in the treatment of schizophrenia: an overview
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32610 3424, USA
    J Clin Psychiatry 72:4-8. 2011
    ....
  4. ncbi Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future
    Rajiv Tandon
    University of Florida, Department of Psychiatry, FL, USA
    Schizophr Res 122:1-23. 2010
    ..We evaluate the potential contribution of pharmacogenomics and other biological markers in optimizing individual treatment and outcome in the future...
  5. ncbi Defining and measuring clinical effectiveness in the treatment of schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 0559, USA
    Psychiatr Serv 56:273-82. 2005
    ..This report describes an approach to define and measure the clinical effectiveness of treatment in achieving these objectives...
  6. ncbi Schizophrenia, "just the facts" 4. Clinical features and conceptualization
    Rajiv Tandon
    Department of Psychiatry, University of Florida College of Medicine, P O Box 100256, Gainesville, FL 32610, USA
    Schizophr Res 110:1-23. 2009
    ..Possible implications for DSM-V and ICD-11 definitions of schizophrenia are discussed...
  7. ncbi Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia
    Henry A Nasrallah
    Department of Psychiatry, University of Mississippi Medical Center, Jackson, Miss, USA
    J Clin Psychiatry 63:12-20. 2002
    ..This article will review the clinical trials examining the efficacy, safety, and tolerability of quetiapine in the treatment of patients with schizophrenia...
  8. ncbi Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder
    Rajiv Tandon
    Department of Psychiatry (Adjunct, University of Florida, Gainesville, FL, USA
    Psychiatry Res 136:211-21. 2005
    ..35 days in the study and a decrease in CGI-I of 0.21 units. These results provide initial validation of the IAQ as a tool for evaluating antipsychotic response in patients with schizophrenia or schizoaffective disorder...
  9. ncbi Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse
    Matcheri S Keshavan
    Department of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Harvard Medical School, Boston, MA 02215, USA
    Schizophr Res 127:3-13. 2011
    ..The mouse may be the way to rescue the trapped elephant!..
  10. ncbi Should overeating and obesity be classified as an addictive disorder in DSM-5?
    Claudia Moreno
    University of Florida College of Medicine, Department of Psychiatry, Gainesville, FL 32611, USA
    Curr Pharm Des 17:1128-31. 2011
    ..In this article, we consider the rationale for this recommendation and evaluate its pros and cons. We summarize how the problem of overeating is addressed in our current classification systems and discuss DSM-5 approaches to the issue...